☆ 4.7 Article

Patterns of Opioid and Non-Opioid Analgesic Consumption in Patients with Post-COVID-19 Conditions

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Past-year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a US National Survey on Drug Use and Health (NSDUH) study

Andrew S. Tubbs et al.

Summary: This study investigated the use of sedative-hypnotic medication among individuals who used or misused opioids. The results showed that there was a high prevalence of sedative benzodiazepine and Z-drug use among opioid users, especially among those who misused opioids. Machine learning models accurately predicted sedative-hypnotic medication use based on opioid use.

JOURNAL OF CLINICAL SLEEP MEDICINE (2022)

添加到收藏夹

Review Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus

Joan B. Soriano et al.

Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Anesthesiology

Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This review or meta-analysis aims to analyze the prevalence of musculoskeletal pain symptoms after COVID-19 infection among hospitalized or nonhospitalized patients. The analysis showed that nearly 10% of individuals infected with SARS-CoV-2 will experience musculoskeletal post-COVID pain symptoms during the first year after infection.

PAIN (2022)

添加到收藏夹

Article Anesthesiology

Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study

Cesar Fernandez-de-las-Penas et al.

Summary: This study investigated the prevalence and risk factors of long-term musculoskeletal post-COVID pain in COVID-19 survivors. The study found that 45.1% of survivors experienced musculoskeletal post-COVID pain 8 months after hospital discharge, and risk factors included female sex, history of musculoskeletal pain, presence of myalgia and headache as COVID-19 symptoms, and days at hospital.

PAIN (2022)

添加到收藏夹

Article Medicine, General & Internal

Risks of mental health outcomes in people with covid-19: cohort study

Yan Xie et al.

Summary: This study finds that survivors of the acute phase of COVID-19 are at increased risk of developing various mental health disorders, including anxiety disorders, depressive disorders, and stress and adjustment disorders. The risk is even higher among those who were hospitalized or used medication. Therefore, addressing and prioritizing the mental health issues of COVID-19 survivors are crucial.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Article Medicine, General & Internal

Pain Burden in Post-COVID-19 Syndrome following Mild COVID-19 Infection

Indre Bileviciute-Ljungar et al.

Summary: A significant number of post-COVID-19 syndrome sufferers experience pain, highlighting the urgent need for pain management.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Psychiatry

COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services

Edoardo G. Ostinelli et al.

Summary: During the COVID-19 pandemic, various institutions and governmental bodies worldwide have developed guidelines and recommendations on managing and caring for individuals with substance use disorders. These guidelines cover general advice, specific drug-related services, and comprehensive recommendations for dealing with challenges posed by the pandemic.

BMC PSYCHIATRY (2022)

添加到收藏夹

Letter Infectious Diseases

Long COVID: current definition

Cesar Fernandez-de-las-Penas

INFECTION (2022)

添加到收藏夹

Review Clinical Neurology

Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management

Pedro Augusto Sampaio Rocha-Filho

Summary: This review discusses the epidemiology, pathophysiology, characteristics, and management of COVID-19-associated headache. Headache is a common clinical symptom of COVID-19, affecting over half of the patients, especially young patients and those with a history of previous headaches. The headache usually occurs early in the symptomatic phase and has similar characteristics to tension-type headaches. The possible pathophysiological mechanisms include viral injury, inflammatory processes, and other mechanisms. Commonly used drugs for treatment include analgesics and nonsteroidal anti-inflammatory drugs.

HEADACHE (2022)

添加到收藏夹

Article Clinical Neurology

Trajectories and Individual Differences in Pain, Emotional Distress, and Prescription Opioid Misuse During the COVID-19 Pandemic: A One-Year Longitudinal Study

Chung Jung Mun et al.

Summary: Recent studies have shown that the COVID-19 pandemic can negatively impact individuals with chronic pain, although the actual effects are relatively small. Interventions that focus on improving pain acceptance may help individuals with chronic pain be resilient during the pandemic.

JOURNAL OF PAIN (2022)

添加到收藏夹

Review Clinical Neurology

Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis

Lavienraj Premraj et al.

Summary: Neurological and neuropsychiatric symptoms that persist or develop three months after the onset of COVID-19 pose a significant threat to the global healthcare system. A systematic review analyzed data from multiple studies and found that fatigue, cognitive dysfunction, and sleep disturbances were key features of post-COVID-19 syndrome. Psychiatric manifestations such as anxiety and depression were also common and increased in prevalence over time.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

添加到收藏夹

Article Psychiatry

Abuse of Non-opioid Analgesics in Germany: Prevalence and Associations Among Self-Medicated Users

Christian Rauschert et al.

Summary: This study aimed to estimate the 12-month prevalence of non-opioid analgesics (NOA) abuse among self-medicated users and identify the risk factors in the general German population. The results showed a weighted 12-month prevalence of NOA abuse of 14.6% among self-medicated users and an extrapolated prevalence of 6.4% in the German population aged 18 to 64. Risk factors for NOA abuse included unexplained physical pain, being underweight, depression, hazardous alcohol use, daily smoking, illegal drug use, and frequent use of NOA. Cannabis use was associated with a lower probability of NOA abuse.

FRONTIERS IN PSYCHIATRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Prevalence of Musculoskeletal Post-COVID Pain in Hospitalized COVID-19 Survivors Depending on Infection with the Historical, Alpha or Delta SARS-CoV-2 Variant

Cesar Fernandez-de-las-Penas et al.

Summary: This study compared the prevalence of musculoskeletal post-COVID pain in COVID-19 survivors infected with different SARS-CoV-2 variants. The findings showed that patients infected with the historical variant had the highest prevalence of musculoskeletal pain, with generalized pain symptoms being most common.

BIOMEDICINES (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

The Association of Opium Abuse with Mortality Amongst Hospitalized COVID-19 Patients in Iranian Population

Alireza Mirahmadizadeh et al.

Summary: This study assessed the risks of mortality among hospitalized COVID-19 patients in southern Iran and found a significant association between opium abuse and mortality. In addition to opium abuse, male gender, older age, and comorbidities were significant risk factors for mortality. Being a healthcare worker and having thyroid gland diseases were protective factors for hospitalized COVID-19 patients.

JOURNAL OF PREVENTION (2022)

添加到收藏夹

Review Clinical Neurology

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research

Edoardo Caronna et al.

Summary: Headache is a common symptom of COVID-19 and may involve activation of the trigeminovascular system. Research on COVID-19 headache not only helps to understand COVID-19 better but also advances knowledge on secondary and primary headaches.

CURRENT PAIN AND HEADACHE REPORTS (2021)

添加到收藏夹

Letter Anesthesiology

Internet Search Interest for Over-the-Counter Analgesics During the COVID-19 Pandemic

Thien Phu Do et al.

PAIN MEDICINE (2021)

添加到收藏夹

Letter Anesthesiology

Internet Searches for Over-the-Counter Analgesics During the COVID-19 Pandemic Outbreak in Italy

Giuseppe Lippi et al.

PAIN MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Follow-up Survey of US Adult Reports of Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic, September 2020

Mark E. Czeisler et al.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

Substitution of Nonpharmacologic Therapy With Opioid Prescribing for Pain During the COVID-19 Pandemic

Byungkyu Lee et al.

Summary: This study analyzed data from 24 million US patients and found that during the COVID-19 pandemic, the proportion of patients receiving opioids for pain management increased, while the use of nonpharmacologic therapy decreased. Opioid prescriptions were more common during the pandemic with longer and more potent doses, potentially worsening the US opioid crisis.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic

Sadaf Arefi Milani et al.

Summary: This study found that compared with men, women were more likely to be prescribed benzodiazepines, Z-hypnotics, and SSRIs/SNRIs, with larger changes in prescription rates over time. The onset of the COVID-19 pandemic was associated with an increase in benzodiazepine prescriptions for women, along with an increase in Z-hypnotics and SSRIs/SNRIs for both men and women, indicating a significant mental health impact of COVID-19-related mitigation measures.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Multidisciplinary Sciences

High-dimensional characterization of post-acute sequelae of COVID-19

Ziyad Al-Aly et al.

Summary: This study comprehensively describes the post-acute sequelae of COVID-19 using national healthcare databases, finding increased risk of death and use of health resources beyond the first 30 days of illness, as well as incident sequelae in various organ systems, increased use of therapeutic agents, and evidence of laboratory abnormalities. The findings show a risk gradient according to the severity of acute COVID-19 infection and highlight the burden of health loss experienced by patients who survive the acute phase.

NATURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic

Janet M. Currie et al.

Summary: The study shows that existing patients maintained access to opioid analgesics and buprenorphine for opioid use disorder during the COVID-19 pandemic. Prescriptions for opioid-naive patients briefly decreased and rebounded, while initiation of buprenorphine remained at a low rate through August 2020.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Review Medicine, General & Internal

Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis

Cesar Fernandez-de-las-Penas et al.

Summary: This meta-analysis revealed that more than 60% of patients with SARS-CoV-2 infection experienced post-COVID-19 symptoms. Fatigue and dyspnea were the most prevalent post-COVID-19 symptoms, especially at 60 and >= 90 days after onset.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Clinical Neurology

Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature

Cesar Fernandez-de-las-Penas et al.

Summary: This study analyzed the prevalence of post-COVID headache in COVID-19 survivors, finding that the prevalence of headache was around 47.1% at onset or hospital admission, 10.2% at 30 days, 16.5% at 60 days, 10.6% at 90 days, and 8.4% at >=180 days. Headache as a symptom at the acute phase was more prevalent in non-hospitalized patients compared to hospitalized patients.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Symptoms, complications and management of long COVID: a review

Olalekan Lee Aiyegbusi et al.

Summary: Patients with long COVID experience a wide range of physical and mental symptoms, with common issues including fatigue, shortness of breath, and headaches. Beyond symptoms and complications, they often report impaired quality of life, mental health issues, and employment problems.

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2021)

添加到收藏夹

Article Environmental Sciences

Consumption of over-the-Counter Drugs: Prevalence and Type of Drugs

Eduardo Sanchez-Sanchez et al.

Summary: The use of over-the-counter drugs has increased recently, but incorrect usage can lead to side effects. A study in Spain found that 78.9% of the population have used OTC drugs, with older individuals using them less. The most commonly used OTC drugs were painkillers.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications

Callie G. Downs et al.

Summary: During the COVID-19 pandemic, the restrictions on elective medical procedures in Texas led to a significant decrease in the dispensing of opioid and benzodiazepine prescriptions, resulting in a large care gap for patients taking these medications.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)

添加到收藏夹

Article Virology

Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis

Pengfei Sun et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

Non-steroidal anti-inflammatory drugs and covid-19

Paul Little

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19

Calum T. Robb et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

添加到收藏夹

Review Clinical Neurology

Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis

Auwal Abdullahi et al.

FRONTIERS IN NEUROLOGY (2020)

添加到收藏夹

Article Substance Abuse

Tramadol non-medical use in Four European countries: A comparative analysis

Janetta L. Iwanicki et al.

DRUG AND ALCOHOL DEPENDENCE (2020)

添加到收藏夹

Article Clinical Neurology

Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study

Javier A. Membrilla et al.

HEADACHE (2020)

添加到收藏夹

Article Anesthesiology

Changes in Interventional Pain Physician Decision-Making, Practice Patterns, and Mental Health During the Early Phase of the SARS-CoV-2 Global Pandemic

Andrew A. Joyce et al.

PAIN MEDICINE (2020)

添加到收藏夹

Review Rheumatology

Rheumatic manifestations of COVID-19: a systematic review and meta-analysis

Jacopo Ciaffi et al.

BMC RHEUMATOLOGY (2020)

添加到收藏夹

Article Geriatrics & Gerontology

Use and Opinions of Prescription Opioids Among Older American Adults: Sociodemographic Predictors

Hanna Grol-Prokopczyk

JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Analgesic use among the Brazilian population: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM)

Tatiane da Silva Dal Pizzol et al.

PLOS ONE (2019)

添加到收藏夹

Review Clinical Neurology

Tramadol Prescription over a 4-Year Period in the USA

Luisa M. Bigal et al.

CURRENT PAIN AND HEADACHE REPORTS (2019)

添加到收藏夹

Article Public, Environmental & Occupational Health

Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study

Gerard Arnoldus Kalkman et al.

LANCET PUBLIC HEALTH (2019)

添加到收藏夹

Article Anesthesiology

Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990-2016

Cristina Bosetti et al.

EUROPEAN JOURNAL OF PAIN (2019)

添加到收藏夹

Article Clinical Neurology

Prescribed opioid analgesic use developments in three Nordic countries, 2006-2017

Ashley Elizabeth Muller et al.

SCANDINAVIAN JOURNAL OF PAIN (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Purchasing Over The Counter (OTC) Medicinal Products Containing Codeine - Easy Access, Advertising, Misuse and Perceptions of Medicinal Risk

John S. G. Wells et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Persistent analgesic use and the association with chronic pain and other risk factors in the population-a longitudinal study from the Tromso Study and the Norwegian Prescription Database

Per-Jostein Samuelsen et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)

添加到收藏夹

Article Public, Environmental & Occupational Health

Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: Impact of gender, age, exercise and prescription of opioids

Ola Dale et al.

BMC PUBLIC HEALTH (2015)

添加到收藏夹

Article Health Care Sciences & Services

Inequality in analgesic prescription in Spain. A gender development issue

Elisa Chilet-Rosell et al.

GACETA SANITARIA (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.